Interleukin 17A: toward a new understanding of psoriasis pathogenesis
Molecular and cellular understanding of psoriasis pathogenesis has evolved considerably
over the last 30 years beginning in the early 1980s when psoriasis was thought to be a skin …
over the last 30 years beginning in the early 1980s when psoriasis was thought to be a skin …
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis …
…, P Fleming, S Siu, J Kraft, C Lynde… - Annals of the …, 2015 - ard.bmj.com
The objective of this systematic literature review was to determine the association between
cardiovascular events (CVEs) and antirheumatic drugs in rheumatoid arthritis (RA) and …
cardiovascular events (CVEs) and antirheumatic drugs in rheumatoid arthritis (RA) and …
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response …
…, KK Singh Ohson, K Barber, C Lynde… - British journal of …, 2020 - academic.oup.com
Background Patients with psoriasis value rapid and complete skin clearance. No head‐to‐head
studies have focused on early responses to interleukin (IL)‐17 vs. IL‐23 inhibitors. …
studies have focused on early responses to interleukin (IL)‐17 vs. IL‐23 inhibitors. …
[HTML][HTML] Two phase 3 trials of adalimumab for hidradenitis suppurativa
…, JJ Crowley, C Lynde… - … England Journal of …, 2016 - Mass Medical Soc
Background Hidradenitis suppurativa is a painful, chronic inflammatory skin disease with
few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor …
few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor …
Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
…, M Appell, M Steinhoff, C Lynde… - Journal of drugs in …, 2014 - europepmc.org
Objective To demonstrate the efficacy and safety of once-daily ivermectin 1% cream in subjects
with moderate to severe PPR. Methods Two identically designed, randomized, double-…
with moderate to severe PPR. Methods Two identically designed, randomized, double-…
Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients
AK Gupta, HC Jain, CW Lynde, P MacDonald… - Journal of the American …, 2000 - Elsevier
A prospective, multicenter study to determine the epidemiology of onychomycosis was
performed in the offices of 3 dermatologists and 1 family physician in Ontario, Canada. In the …
performed in the offices of 3 dermatologists and 1 family physician in Ontario, Canada. In the …
[HTML][HTML] Phase 3 trial of nemolizumab in patients with prurigo nodularis
Background Prurigo nodularis is a chronic, debilitating, and severely pruritic neuroimmunologic
skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist, down-…
skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist, down-…
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis …
…, A Dansereau, HCH Hong, C Lynde… - Dermatologic …, 2007 - journals.lww.com
BACKGROUND Hyperhidrosis can have profound effects on a patient's quality of life. Current
treatment guidelines ignore disease severity. OBJECTIVE The objective was to establish …
treatment guidelines ignore disease severity. OBJECTIVE The objective was to establish …
Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada‐a multicenter survey of 2001 patients
AK Gupta, HC Jain, CW Lynde… - International journal …, 1997 - Wiley Online Library
Background Questionnaire studies have been used to determine the prevalence of onychomycosis
in the United Kingdom and Europe. One disadvantage of this methodology is that the …
in the United Kingdom and Europe. One disadvantage of this methodology is that the …
The burden of chronic spontaneous urticaria is substantial: real‐world evidence from ASSURE‐CSU
…, C Grattan, K Hollis, A Knulst, JP Lacour, C Lynde… - Allergy, 2017 - Wiley Online Library
Background Chronic spontaneous urticaria ( CSU ) can be debilitating, difficult to treat, and
frustrating for patients and physicians. Real‐world evidence for the burden of CSU is limited. …
frustrating for patients and physicians. Real‐world evidence for the burden of CSU is limited. …